Elevated 18:1 lysophosphatidylcholine contributes to neuropathic pain in peripheral nerve injury.
Authors
Ren J, Yu L, Lin J, Liu Y, Ma L, Huang Y, Sun N, Deng Y, Zhong D, Zhou B, Jiang B, Yan M
Abstract
Neuropathic pain is a maladaptive and chronic condition with limited effective treatments. Although recent studies have suggested that certain lipid metabolites, like lysophosphatidylcholine (LPC), may contribute to chronic pain, their specific roles and mechanisms remain unclear.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
